Organogenesis Holdings (ORGO) Operating Leases (2021 - 2025)
Historic Operating Leases for Organogenesis Holdings (ORGO) over the last 5 years, with Q3 2025 value amounting to $23.5 million.
- Organogenesis Holdings' Operating Leases rose 316.88% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year increase of 316.88%. This contributed to the annual value of $25.2 million for FY2024, which is 57.88% up from last year.
- Per Organogenesis Holdings' latest filing, its Operating Leases stood at $23.5 million for Q3 2025, which was up 316.88% from $24.6 million recorded in Q2 2025.
- Over the past 5 years, Organogenesis Holdings' Operating Leases peaked at $46.9 million during Q4 2021, and registered a low of $15.0 million during Q1 2021.
- Its 5-year average for Operating Leases is $30.9 million, with a median of $25.6 million in 2025.
- Over the last 5 years, Organogenesis Holdings' Operating Leases had its largest YoY gain of 20145.0% in 2022, and its largest YoY loss of 5533.02% in 2022.
- Over the past 5 years, Organogenesis Holdings' Operating Leases (Quarter) stood at $46.9 million in 2021, then tumbled by 55.33% to $20.9 million in 2022, then increased by 19.6% to $25.1 million in 2023, then grew by 0.58% to $25.2 million in 2024, then dropped by 6.71% to $23.5 million in 2025.
- Its last three reported values are $23.5 million in Q3 2025, $24.6 million for Q2 2025, and $25.6 million during Q1 2025.